Viewing Study NCT03392428


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2025-12-26 @ 11:13 AM
Study NCT ID: NCT03392428
Status: COMPLETED
Last Update Posted: 2022-06-13
First Post: 2017-12-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module